Enflurane
(Redirected from Alyrane)
Enflurane is a halogenated ether used as an inhalational anesthetic. It was first synthesized in 1963 by Ross Terrell and introduced into clinical practice in the early 1970s. Enflurane is known for its rapid onset and recovery times, making it a popular choice for general anesthesia.
Chemical Properties[edit | edit source]
Enflurane is chemically designated as 2-chloro-1-(difluoromethoxy)-1,1,2-trifluoroethane. It is a clear, colorless, and volatile liquid at room temperature. The molecular formula of enflurane is C3H2ClF5O, and it has a molecular weight of 184.5 g/mol.
Pharmacology[edit | edit source]
Enflurane works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. It is believed to act on GABA receptors, enhancing the inhibitory effects of the neurotransmitter gamma-aminobutyric acid. Enflurane also affects other ion channels, including NMDA receptors and potassium channels.
Clinical Use[edit | edit source]
Enflurane is administered via inhalation using a vaporizer. It is often used in combination with other anesthetic agents such as nitrous oxide and muscle relaxants. The typical concentration for induction ranges from 2-4%, while maintenance concentrations are usually between 0.5-2%.
Advantages[edit | edit source]
- Rapid induction and recovery
- Minimal metabolism, reducing the risk of toxic metabolites
- Good muscle relaxation properties
Disadvantages[edit | edit source]
- Potential for seizure activity, especially at high concentrations
- Cardiovascular depression, leading to hypotension and bradycardia
- Respiratory depression
Side Effects[edit | edit source]
Common side effects of enflurane include:
- Nausea and vomiting
- Shivering
- Hypotension
- Respiratory depression
Rare but serious side effects include:
- Seizures
- Malignant hyperthermia
- Hepatotoxicity
History[edit | edit source]
Enflurane was developed as an alternative to earlier anesthetics like halothane and ether. Its introduction marked a significant advancement in the field of anesthesiology, offering a safer and more controllable option for general anesthesia.
Discontinuation[edit | edit source]
Due to the development of newer anesthetics with better safety profiles, such as isoflurane and sevoflurane, the use of enflurane has declined significantly. It is now rarely used in clinical practice.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD